Kindred Biosciences, Inc., a biopharmaceutical company focused on saving and improving the lives of pets, announced that it has acquired a manufacturing facility in Elwood, Kansas. The purchase of this property, formerly owned by Boehringer Ingelheim and by Strategic Veterinary Pharmaceuticals, Inc., includes approximately 8 acres of land and two buildings encompassing approximately 180,000 square feet with clean rooms, utility, equipment, and related quality documentation suitable for small molecule and biologics manufacturing. The total purchase price was $3,750,000 and the company expects to close within 30-days. (See company press release here)
“We are very excited to become a brick and mortar addition to the Kansas City Animal Health Corridor. While we already employ top talent in the Kansas area, this acquisition will allow us to recruit additional talent to support the manufacture of drugs and biologics for companion animals,” stated Denise Bevers, Co-Founder and COO of KindredBio.
Kimberly Young, president of the KC Animal Health Corridor, assisted the company with its site search and selection of a Corridor location.
“Kindred Bio is a welcome addition to the Corridor as they kick off commercialization of the company’s first product offerings and create new jobs in our region,” Young said. “More and more, the growth of the animal health industry in the Corridor is reliant on young companies taking innovative products and services from the lab to the marketplace.”
Organizations that assisted in attracting KindredBio to the region were the KC Area Development Council, the State of Kansas, the Kansas Department of Commerce, Westar Energy, KC Animal Health Corridor, and the Doniphan County Economic Development Commission.
“It was pleasure working with Kindred Bio and other area partners to help facilitate the entrance of such a fantastic company and employer to Doniphan County.” Adrienne Korson, Director of Economic Development in Doniphan County stated. “We look forward to helping assist in the future success of such a promising and cutting-edge enterprise, as KindredBio grows and fortifies our area as an important part of the animal health corridor.”